Search

Your search keyword '"Ruiz-Argüelles GJ"' showing total 354 results

Search Constraints

Start Over You searched for: Author "Ruiz-Argüelles GJ" Remove constraint Author: "Ruiz-Argüelles GJ"
354 results on '"Ruiz-Argüelles GJ"'

Search Results

3. Significance of one human leukocyte antigen mismatch on outcome of nonmyeloablative allogeneic stem cell transplantation from related donors using the Mexican schedule.

4. Acute promyelocytic leukemia can be fully treated on an outpatient basis: a single institution experience.

5. More about post-transplant cyclophosphamide in haploidentical grafts: full or reduced doses?

6. The Latin-American Experience in POEMS Syndrome: A Study of the GELAMM (Grupo de Estudio Latinoamericano de Mieloma Múltiple).

7. Neutrophil to lymphocyte ratio and systemic immune-inflammatory index as markers of response to autologous hematopoietic stem cell transplantation in persons with multiple sclerosis.

8. Prevalence and Consequences of a Delayed Diagnosis in Multiple Myeloma: A Single Institution Experience.

11. The consequences of delayed diagnosis and treatment in persons with multiple sclerosis given autologous hematopoietic stem cell transplantation.

12. Therapeutic Choices in Patients with Ph-Positive Chronic Myelogenous Leukemia In Mexico in the Era of Tyrosine Kinase Inhibitors: Stem Cell Transplantation or Tyrosine Kinase Inhibitors? Fifteen Years Later.

13. Second Autologous Hematopoietic Stem Cell Transplantation in Multiple Sclerosis: A Single-Center Prospective Experience.

14. Impaired lung function in multiple sclerosis: a single-center observational study in 371 persons.

15. SARS-CoV-2-infection in the setting of autotransplants for multiple sclerosis.

16. In persons with CIDP, auto-HSCT can be conducted fully on an outpatient basis and induces significant clinical responses: A prospective study in a single center.

17. Can doses of post-transplantation cyclophosphamide in haploidentical stem cell allografts be reduced?

18. Serum Electrolyte and Metabolic Changes During Conditioning of Autologous Hematopoietic Stem Cell Transplantation in Patients with Autoimmune Diseases: A Prospective Study in a Single Institution.

19. Long-term results of autografting persons with multiple sclerosis are better in those not exposed to prior disease-modifying therapies.

20. Therapy of childhood acute lymphoblastic leukemia in resource-poor geospaces.

23. [Clinical research and the pharmaceutical industry].

24. Cannabinoids and their therapeutic use.

25. Some reflections about physicians' updating.

26. Conducting hematopoietic stem cell transplantation in low and middle income countries.

27. Hematopoietic stem cell transplantation activity in Mexico during the COVID19 pandemic: on the way to recovery.

28. Long-term results of the treatment of adolescents and adults with acute lymphoblastic leukemia with a pediatric-inspired regimen delivered on an outpatient basis: A single institution experience.

29. Non-alcoholic fatty liver disease and thrombocytopenia IV: its association with granulocytopenia.

30. SARS-CoV-2 vaccination patterns in a private hematology and internal medicine outpatient clinic.

31. Primary Thrombophilia XVII: A Narrative Review of Sticky Platelet Syndrome in México.

32. Long term survival in multiple myeloma: a single institution experience in underprivileged circumstances.

34. Splitting the Total Dose of Cyclophosphamide in Two Blocks Apart during the Conditioning of Autologous Hematopoietic Stem Cell Transplantation in Multiple Sclerosis Results in Diminished Cardiotoxicity: Experience in 1,000 Patients.

35. Who judges medical practice?

36. Families of doctors at Academia Nacional de Medicina de México.

37. Role of individual physicians in pharmacovigilance.

38. Moral Distress: Its Manifestations in Healthy Donors during Peripheral Blood Hematopoietic Stem Cell Harvesting.

39. Long-term results of the treatment of Hodgkin's lymphoma in a resource-constrained setting: Real-world data from a single center.

40. Prescription Patterns of Daratumumab in Patients with Multiple Myeloma in Underprivileged Circumstances: A Multicenter Experience in Mexico.

42. Genetic variants associated with methotrexate-induced mucositis in cancer treatment: A systematic review and meta-analysis.

43. The 1,000th Transplant for Multiple Sclerosis and Other Autoimmune Disorders at the HSCT-México Program: A Myriad of Experiences and Knowledge.

44. Lessons Learned Treating Patients with Multiple Myeloma in Resource-Constrained Settings.

45. PERSPECTIVES IN DIAGNOSIS AND THERAPEUTICS IN HEMATOLOGY.

46. Primary Thrombophilia XVI: A Look at the Genotype of the Sticky Platelet Syndrome Phenotype.

48. Different outcomes for transplant-eligible newly diagnosed multiple myeloma patients in Latin America according to the public versus private management: a GELAMM study.

49. Mélange intéressante : COVID-19, autologous transplants and multiple sclerosis.

50. Up to half of patients diagnosed with chronic lymphocytic leukemia in México may not require treatment.

Catalog

Books, media, physical & digital resources